Drug Database
Back to search

France· FR:62519824

XEVUDY 500 mg, solution à diluer pour perfusion

A sotrovimab product containing sotrovimab, registered in France by GLAXOSMITHKLINE TRADING SERVICES (IRLANDE). The same ATC class is registered in 7 of our 19 countries.

ATC J06BD05

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedXEVUDY 500 mg, solution à diluer pour…ATCJ06BD05REGISTER NO.FR:62519824PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sotrovimabAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sotrovimab is registered in 7 of 19 countries.

Countries holding a registration under ATC J06BD05 (sotrovimab), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 5 of them publish a price we can compare per daily dose
Search sotrovimab products by name

Sotrovimab · ATC J06BD05

7 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Polandprice
  • Spainprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
SOTROVIMAB
Manufacturer
GLAXOSMITHKLINE TRADING SERVICES (IRLANDE)
Country
France (FR)
ATC code
J06BD05
ATC class
Sotrovimab
Defined daily dose
0.5 g, P
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955086451
    1 flacon(s) en verre de 8 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sotrovimab in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sotrovimab products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f7d95a55-32ae-4a81-b2bf-d0896474621b
GET /v1/drugs/f7d95a55-32ae-4a81-b2bf-d0896474621b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "62519824",
  "date_amm": "2021-12-17",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/21/1562",
  "substance": "SOTROVIMAB",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation abrogée",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "solution à diluer pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Oui"
}
API referenceMCP serverPlans

See everything about sotrovimab.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console